Bleichroeder’s Ernexa Therapeutics Warrants ERNAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63.4K Hold
2,000,000
– – 0.01% 97
2026
Q2
$143K Hold
2,000,000
– – 0.03% 64
2026
Q1
$56K Buy
+2,000,000
New +$118K 0.01% 68

Other funds holding ERNAW

Bleichroeder's ERNAW Position: Q3 2026 in Review

Bleichroeder held its Ernexa Therapeutics Warrants (ERNAW) position steady in Q3 2026 at 2,000,000 shares worth $63.4K. The position accounts for 0.01% of the portfolio, ranked #97.

Bleichroeder first reported a position in ERNAW in Q1 2026 and has held it in 3 quarters since. The position peaked at $143K in Q2 2026. 3 funds tracked by Wall St. Rank hold ERNAW as of Q3 2026.

  • Bleichroeder held 2,000,000 shares of Ernexa Therapeutics Warrants worth $63.4K as of Q3 2026.
  • Bleichroeder left its Ernexa Therapeutics Warrants share count unchanged in Q3 2026.
  • Ernexa Therapeutics Warrants made up 0.01% of Bleichroeder's portfolio in Q3 2026, its #97 holding.
  • Bleichroeder first reported a position in Ernexa Therapeutics Warrants in Q1 2026 and has held it in 3 quarters since.
  • Bleichroeder's Ernexa Therapeutics Warrants position peaked at $143K in Q2 2026.
  • 3 funds tracked by Wall St. Rank held Ernexa Therapeutics Warrants as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.